Lupin intros generic Temovate ointment
Lupin is launching its generic Temovate (clobetasol propionate ointment 0.05%). The product was previously approved by the Food and Drug Administration.
The product is a super-high potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Clobetasol propionate ointment 0.05% had a market value of approximately $93.4 million, according to June 2018 IQVIA data.
The product is a super-high potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Clobetasol propionate ointment 0.05% had a market value of approximately $93.4 million, according to June 2018 IQVIA data.